{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:55:03Z","timestamp":1759366503381,"version":"build-2065373602"},"reference-count":58,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T00:00:00Z","timestamp":1639094400000},"content-version":"am","delay-in-days":374,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.revmed.2020.06.013","type":"journal-article","created":{"date-parts":[[2020,7,26]],"date-time":"2020-07-26T23:13:33Z","timestamp":1595805213000},"page":"822-828","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["La fibrose r\u00e9trop\u00e9riton\u00e9ale idiopathique"],"prefix":"10.1016","volume":"41","author":[{"given":"A.","family":"Le Joncour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Saadoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Cacoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2020.06.013_bb0005","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S0022-5347(17)69482-5","article-title":"Bilateral ureteral obstruction due to envelopment and compression by an inflammatory retroperitoneal process","volume":"59","author":"Ormond","year":"1948","journal-title":"J Urol"},{"key":"10.1016\/j.revmed.2020.06.013_bb0010","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0140-6736(04)16100-X","article-title":"Asbestos exposure as a risk factor for retroperitoneal fibrosis","volume":"363","author":"Uibu","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2020.06.013_bb0015","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MD.0b013e3181afc420","article-title":"Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation","volume":"88","author":"van Bommel","year":"2009","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2020.06.013_bb0020","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0022-3468(03)00590-6","article-title":"Presentation of idiopathic retroperitoneal fibrosis in the pediatric population","volume":"38","author":"Miller","year":"2003","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.revmed.2020.06.013_bb0025","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3389\/fimmu.2019.00693","article-title":"Clinical and prognostic significance of serum IgG4 in chronic periaortitis. An analysis of 113 patients","volume":"10","author":"Maritati","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.revmed.2020.06.013_bb0030","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4065\/mcp.2010.0663","article-title":"Idiopathic retroperitoneal fibrosis: a retrospective review of clinical presentation, treatment, and outcomes","volume":"86","author":"Kermani","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.revmed.2020.06.013_bb0035","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1210\/jc.2011-0617","article-title":"Clinical review: Riedel\u2019s thyroiditis: a clinical review","volume":"96","author":"Hennessey","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.revmed.2020.06.013_bb0040","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2214\/AJR.07.3629","article-title":"Retroperitoneal fibrosis: a review of clinical features and imaging findings","volume":"191","author":"Cronin","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.revmed.2020.06.013_bb0045","doi-asserted-by":"crossref","first-page":"181","DOI":"10.7326\/M13-2648","article-title":"Asbestos and smoking as risk factors for idiopathic retroperitoneal fibrosis: a case-control study","volume":"161","author":"Goldoni","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2020.06.013_bb0050","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000680","article-title":"IgG4-related disease: dataset of 235 consecutive patients","volume":"94","author":"Inoue","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2020.06.013_bb0055","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s13075-017-1467-x","article-title":"New clues to the nature of immunoglobulin G4-related disease: a retrospective Japanese multicenter study of baseline clinical features of 334 cases","volume":"19","author":"Yamada","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.revmed.2020.06.013_bb0060","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/art.39205","article-title":"IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients","volume":"67","author":"Wallace","year":"2015","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"10.1016\/j.revmed.2020.06.013_bb0065","doi-asserted-by":"crossref","first-page":"42","DOI":"10.23876\/j.krcp.18.0052","article-title":"Retroperitoneal fibrosis in the era of immunoglobulin G4-related disease","volume":"38","author":"Choi","year":"2019","journal-title":"Kidney Res Clin Pract"},{"key":"10.1016\/j.revmed.2020.06.013_bb0070","first-page":"371","article-title":"No specific imaging pattern can help differentiate IgG4-related disease from idiopathic retroperitoneal fibrosis: 18 histologically proven cases","volume":"36","author":"Forestier","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2020.06.013_bb0075","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3109\/14397595.2014.931908","article-title":"Clinicopathologic characteristics of IgG4-related retroperitoneal fibrosis among patients initially diagnosed as having idiopathic retroperitoneal fibrosis","volume":"25","author":"Koo","year":"2015","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.revmed.2020.06.013_bb0080","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1080\/03009742.2018.1551963","article-title":"IgG4-related disease in patients with newly diagnosed idiopathic retroperitoneal fibrosis: a population-based Danish study","volume":"48","author":"Lomborg","year":"2019","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.revmed.2020.06.013_bb0085","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/03009742.2018.1497700","article-title":"Long-term outcomes and predictors of a large cohort of idiopathic retroperitoneal fibrosis patients: a retrospective study","volume":"48","author":"Zhao","year":"2019","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.revmed.2020.06.013_bb0090","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1148\/rg.332125085","article-title":"Retroperitoneal fibrosis: role of imaging in diagnosis and follow-up","volume":"33","author":"Caiafa","year":"2013","journal-title":"Radiographics"},{"key":"10.1016\/j.revmed.2020.06.013_bb0095","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0022-5347(17)54466-3","article-title":"Computerized tomography in the diagnosis of retroperitoneal fibrosis","volume":"126","author":"Feinstein","year":"1981","journal-title":"J Urol"},{"key":"10.1016\/j.revmed.2020.06.013_bb0100","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1148\/rg.334125081","article-title":"Chronic fibrosing conditions in abdominal imaging","volume":"33","author":"George","year":"2013","journal-title":"RadioGraphics"},{"key":"10.1016\/j.revmed.2020.06.013_bb0105","first-page":"871","article-title":"Computed tomography parameters can be used as predictive markers for the improvement of renal function in patients with retroperitoneal fibrosis","volume":"33","author":"Gao","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2020.06.013_bb0110","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1148\/radiol.14131565","article-title":"Role of diffusion-weighted MR imaging in the differentiation of benign retroperitoneal fibrosis from malignant neoplasm: preliminary study","volume":"272","author":"Bakir","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.revmed.2020.06.013_bb0115","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MD.0b013e31826b1c1d","article-title":"Malignant retroperitoneal fibrosis: MRI characteristics in 50 patients","volume":"91","author":"Mirault","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2020.06.013_bb0120","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s00259-012-2144-6","article-title":"The value of (18)F-FDG PET\/CT in the assessment of active idiopathic retroperitoneal fibrosis","volume":"39","author":"Moroni","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.revmed.2020.06.013_bb0125","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1093\/ndt\/gfq051","article-title":"Positron emission tomography as a tool for the \u201ctailored\u201d management of retroperitoneal fibrosis: a nephro-urological experience","volume":"25","author":"Piccoli","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.revmed.2020.06.013_bb0130","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.eururo.2016.10.046","article-title":"[18F]-fluorodeoxyglucose positron emission tomography in the diagnosis, treatment stratification, and monitoring of patients with retroperitoneal fibrosis: a prospective clinical study","volume":"71","author":"Fernando","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.revmed.2020.06.013_bb0135","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(06)68035-5","article-title":"Retroperitoneal fibrosis","volume":"367","author":"Vaglio","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2020.06.013_bb0140","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/sj.ki.5002427","article-title":"Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis","volume":"72","author":"Corradi","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.revmed.2020.06.013_bb0145","doi-asserted-by":"crossref","first-page":"928","DOI":"10.2298\/VSP140426076H","article-title":"Idionathic retroneritoneal fibrosis: a report on 15 patients","volume":"72","author":"Hadzi-Djoki\u0107","year":"2015","journal-title":"Vojnosanit Pregl"},{"key":"10.1016\/j.revmed.2020.06.013_bb0150","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s11255-017-1608-9","article-title":"Idiopathic retroperitoneal fibrosis: clinical features and long-term renal function outcome","volume":"49","author":"Zahran","year":"2017","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.revmed.2020.06.013_bb0155","first-page":"226","article-title":"Robotic ureterolysis, retroperitoneal biopsy, and omental wrap for the treatment of ureteral obstruction due to idiopathic retroperitoneal fibrosis","volume":"8","author":"Mufarrij","year":"2006","journal-title":"Rev Urol"},{"key":"10.1016\/j.revmed.2020.06.013_bb0160","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1046\/j.1464-410X.2002.02677.x","article-title":"Surgery for idiopathic retroperitoneal fibrosis by ureterolysis and ureteric protection with a posterior pre-peritoneal fat flap","volume":"89","author":"Garc\u00eda Penalver","year":"2002","journal-title":"BJU Int"},{"key":"10.1016\/j.revmed.2020.06.013_bb0165","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0140-6736(11)60934-3","article-title":"Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial","volume":"378","author":"Vaglio","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2020.06.013_bb0170","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1053\/j.ajkd.2007.02.268","article-title":"Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone","volume":"49","author":"van Bommel","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.revmed.2020.06.013_bb0175","first-page":"338","article-title":"Retroperitoneal fibrosis: report of 12 cases and a review of the literature","volume":"39","author":"van Bommel","year":"1991","journal-title":"Neth J Med"},{"key":"10.1016\/j.revmed.2020.06.013_bb0180","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/ckj\/sfv148","article-title":"Outcome in patients with idiopathic retroperitoneal fibrosis treated with corticosteroid or tamoxifen monotherapy","volume":"9","author":"van der Bilt","year":"2016","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.revmed.2020.06.013_bb0185","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ejim.2012.11.010","article-title":"Long-term safety and efficacy of a tamoxifen-based treatment strategy for idiopathic retroperitoneal fibrosis","volume":"24","author":"van Bommel","year":"2013","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.revmed.2020.06.013_bb0190","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000357814","article-title":"Tamoxifen monotherapy in the treatment of retroperitoneal fibrosis","volume":"93","author":"Brandt","year":"2014","journal-title":"Urol Int"},{"key":"10.1016\/j.revmed.2020.06.013_bb0195","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1093\/ndt\/gfl228","article-title":"Long-term outcome of idiopathic retroperitoneal fibrosis treated with surgical and\/or medical approaches","volume":"21","author":"Moroni","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.revmed.2020.06.013_bb0200","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1056\/NEJMoa052258","article-title":"A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer","volume":"353","author":"Beat","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2020.06.013_bb0205","doi-asserted-by":"crossref","first-page":"31","DOI":"10.7326\/0003-4819-154-1-201101040-00005","article-title":"Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis: a case series","volume":"154","author":"Scheel","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2020.06.013_bb0210","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.amjmed.2003.08.033","article-title":"Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: a retrospective analysis of 26 cases","volume":"116","author":"Marcolongo","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.revmed.2020.06.013_bb0215","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3109\/00365599409181272","article-title":"Retroperitoneal fibrosis treated with methylprednisolon pulse and disease-modifying antirheumatic drugs","volume":"28","author":"Harreby","year":"1994","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.revmed.2020.06.013_bb0220","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/annrheumdis-2011-200148","article-title":"Cyclophosphamide is a highly effective and safe induction therapy in chronic periaortitis: a long-term follow-up of 35 patients with chronic periaortitis","volume":"71","author":"Binder","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2020.06.013_bb0225","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejim.2010.02.008","article-title":"(18)F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis","volume":"21","author":"Jansen","year":"2010","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.revmed.2020.06.013_bb0230","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1136\/annrheumdis-2013-203267","article-title":"Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis","volume":"72","author":"Alberici","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2020.06.013_bb0235","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/rheumatology\/kev438","article-title":"Predictors of disease relapse in IgG4-related disease following rituximab","volume":"55","author":"Wallace","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2020.06.013_bb0240","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5414\/CNCS109321","article-title":"Rituximab for retroperitoneal fibrosis due to IgG4-related disease: a case report and literature review","volume":"6","author":"Almeqdadi","year":"2018","journal-title":"Clin Nephrol Case Stud"},{"key":"10.1016\/j.revmed.2020.06.013_bb0245","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012631","article-title":"Rituximab for idiopathic and IgG4-related retroperitoneal fibrosis","volume":"97","author":"Wallwork","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2020.06.013_bb0250","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1002\/art.38032","article-title":"Interleukin-6 as an inflammatory mediator and target of therapy in chronic periaortitis","volume":"65","author":"Vaglio","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2020.06.013_bb0255","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejim.2019.01.019","article-title":"Persistent FDG\/PET CT uptake in idiopathic retroperitoneal fibrosis helps identifying patients at a higher risk for relapse","volume":"62","author":"Morin","year":"2019","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.revmed.2020.06.013_bb0260","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s11739-016-1426-6","article-title":"Diagnosis and follow-up of idiopathic retroperitoneal fibrosis: role of (18)F-FDG-PET\/CT and biochemical parameters in patients with renal involvement","volume":"11","author":"Fofi","year":"2016","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.revmed.2020.06.013_bb0265","first-page":"146","article-title":"Disease activity and vascular involvement in retroperitoneal fibrosis: first experience with fully integrated 18F-fluorodeoxyglucose positron emission tomography\/magnetic resonance imaging compared to clinical and laboratory parameters","volume":"35","author":"Thuermel","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2020.06.013_bb0270","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/art.24461","article-title":"Do acute-phase reactants predict response to glucocorticoid therapy in retroperitoneal fibrosis?","volume":"61","author":"Magrey","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2020.06.013_bb0275","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.eururo.2017.09.024","article-title":"[18F]-Fluorodeoxyglucose positron emission tomography and response to therapy in idiopathic retroperitoneal fibrosis","volume":"73","author":"Accorsi Buttini","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.revmed.2020.06.013_bb0280","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s00296-014-3002-6","article-title":"Retroperitoneal fibrosis: a clinical and outcome analysis of 58 cases and review of literature","volume":"34","author":"Liu","year":"2014","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.revmed.2020.06.013_bb0285","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s10157-019-01759-w","article-title":"Risk factors for relapse and long-term outcome of idiopathic retroperitoneal fibrosis","volume":"23","author":"Moriconi","year":"2019","journal-title":"Clin Exp Nephrol"},{"issue":"6","key":"10.1016\/j.revmed.2020.06.013_bb0290","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1053\/j.ajkd.2019.04.020","article-title":"Idiopathic retroperitoneal fibrosis: long-term risk and predictors of relapse","volume":"74","author":"Raffiotta","year":"2019","journal-title":"Am J Kidney Dis"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866320302241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866320302241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:42:42Z","timestamp":1759336962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866320302241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":58,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0248866320302241"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2020.06.013","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"La fibrose r\u00e9trop\u00e9riton\u00e9ale idiopathique","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2020.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}